Patent 9192718 was granted and assigned to Geno on November, 2015 by the United States Patent and Trademark Office.
A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.